CHRISTOPHER J JOYCE, the Chief Legal and Admin. Officer of $ALHC, sold 19,706 shares of the company on 12-08-2025 for an estimated $380,905. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.7% of their shares of this class of stock. Following this trade, they now own 323,886 shares of this class of $ALHC stock.
$ALHC Insider Trading Activity
$ALHC insiders have traded $ALHC stock on the open market 40 times in the past 6 months. Of those trades, 0 have been purchases and 40 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- ATLANTIC, L.P. GENERAL has made 0 purchases and 2 sales selling 19,706,096 shares for an estimated $315,494,596.
- ATLANTIC (ALN HLTH), L.P. GENERAL has made 0 purchases and 2 sales selling 19,706,096 shares for an estimated $315,494,596.
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 9 sales selling 1,435,018 shares for an estimated $22,546,900.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 6 sales selling 305,662 shares for an estimated $4,824,168.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 5 sales selling 147,034 shares for an estimated $2,431,524.
- JOSEPH S KONOWIECKI has made 0 purchases and 6 sales selling 120,908 shares for an estimated $2,090,753.
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 4 sales selling 130,398 shares for an estimated $1,981,855.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 4 sales selling 66,136 shares for an estimated $1,136,491.
- ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 31,431 shares for an estimated $494,209.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ALHC Hedge Fund Activity
We have seen 151 institutional investors add shares of $ALHC stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ATLANTIC, L.P. removed 19,706,096 shares (-44.8%) from their portfolio in Q3 2025, for an estimated $343,871,375
- WELLINGTON MANAGEMENT GROUP LLP added 6,940,277 shares (+167.3%) to their portfolio in Q3 2025, for an estimated $121,107,833
- DURABLE CAPITAL PARTNERS LP removed 3,589,745 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $50,256,430
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,379,326 shares (+154.0%) to their portfolio in Q3 2025, for an estimated $58,969,238
- FMR LLC removed 2,956,528 shares (-26.8%) from their portfolio in Q3 2025, for an estimated $51,591,413
- BROAD BAY CAPITAL MANAGEMENT, LP added 2,374,845 shares (+inf%) to their portfolio in Q3 2025, for an estimated $41,441,045
- CITADEL ADVISORS LLC removed 2,158,673 shares (-25.9%) from their portfolio in Q3 2025, for an estimated $37,668,843
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ALHC Revenue
$ALHC had revenues of $993.7M in Q3 2025. This is an increase of 43.51% from the same period in the prior year.
You can track ALHC financials on Quiver Quantitative's ALHC stock page.
$ALHC Analyst Ratings
Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/24/2025
- Goldman Sachs issued a "Buy" rating on 10/14/2025
To track analyst ratings and price targets for $ALHC, check out Quiver Quantitative's $ALHC forecast page.
$ALHC Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 6 analysts offer price targets for $ALHC in the last 6 months, with a median target of $19.0.
Here are some recent targets:
- John Stansel from JP Morgan set a target price of $20.0 on 11/24/2025
- Andrew Mok from Barclays set a target price of $18.0 on 11/03/2025
- Kevin Caliendo from UBS set a target price of $18.0 on 10/31/2025
- Scott Fidel from Goldman Sachs set a target price of $21.0 on 10/14/2025
- Matthew Gillmor from Keybanc set a target price of $21.0 on 08/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
